CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 62 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | -100.0% | 272 | -90.9% | 0.00% | – |
| Q2 2021 | $8,000 | +166.7% | 3,000 | +200.0% | 0.00% | – |
| Q1 2021 | $3,000 | +200.0% | 1,000 | +371.7% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 212 | +0.5% | 0.00% | – |
| Q2 2020 | $1,000 | – | 211 | +0.5% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 210 | -17.0% | 0.00% | – |
| Q3 2018 | $2,000 | – | 253 | +1586.7% | 0.00% | – |
| Q2 2018 | $0 | – | 15 | +400.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 3 | -96.4% | 0.00% | – |
| Q4 2017 | $1,000 | -90.9% | 84 | -88.3% | 0.00% | – |
| Q3 2017 | $11,000 | – | 720 | +2566.7% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 27 | -76.9% | 0.00% | – |
| Q1 2017 | $2,000 | 0.0% | 117 | -25.9% | 0.00% | – |
| Q4 2016 | $2,000 | – | 158 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $7,501,161 | 1.96% |
| TOWERVIEW LLC | 205,000 | $469,450 | 0.31% |
| Orbimed Advisors | 6,943,654 | $15,900,968 | 0.29% |
| CHI Advisors LLC | 200,000 | $458,000 | 0.14% |
| BVF INC/IL | 1,370,947 | $3,139,469 | 0.09% |
| SAMLYN CAPITAL, LLC | 2,105,930 | $4,822,580 | 0.08% |
| MYDA Advisors LLC | 100,000 | $229,000 | 0.07% |
| DIFESA CAPITAL MANAGEMENT, LP | 10,000 | $22,900 | 0.06% |
| JACKSON SQUARE CAPITAL, LLC | 63,773 | $146,040 | 0.06% |
| CORNERCAP INVESTMENT COUNSEL INC | 97,248 | $222,698 | 0.04% |